SCHEMBL14329141

SCHEMBL14329141

COOCCOCCOCC(COCC(COCC(COCC(COCC(COCC(COCCOCCCOO)OCCOCCOC=O)OCCOCCOC=O)OCCOCCOC=O)OCCOCCOC=O)OCCOCCOC=O)OCCOCCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12317193 0.92 LPAR1 (0.32) —
SCHEMBL12317240 0.89 LPAR1 (0.34) —
SCHEMBL19543437 0.82 — —
SCHEMBL12914841 0.80 LPAR1 (0.39) —
SCHEMBL13155260 0.77 LPAR1 (0.32) —
SCHEMBL31380117 0.69 HSD17B10 (0.35) —
SCHEMBL21733117 0.69 HSD17B10 (0.35) —
SCHEMBL13155378 0.68 LPAR1 (0.36) —
SCHEMBL21935885 0.68 LPAR1 (0.35) —
SCHEMBL25869902 0.67 LPAR1 (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120329807-A1 Multimeric VLA-4 Antagonists Comprising Polymers Moieties ELAN PHARMACEUTICALS, INC. (US) 2012-12-27 — — US disclosed
Send feedback